Common Stock, Shares, Outstanding of SAB Biotherapeutics, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
SAB Biotherapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • SAB Biotherapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 47,609,899, a 413% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

SAB Biotherapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 47,609,899 +38,321,031 +413% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 47,493,994 +38,264,720 +415% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 9,291,697 +62,423 +0.68% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 9,291,697 +62,423 +0.68% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 9,288,868 +63,374 +0.69% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 9,229,274 -43,089,882 -82% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 9,229,274 -43,085,382 -82% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 9,229,274 -41,168,488 -82% 31 Mar 2024 10-Q 20 May 2024 2024 Q1
Q4 2023 9,225,494 +4,185,258 +83% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 52,319,156 +9,288,271 +22% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 52,314,656 +9,283,771 +22% 30 Jun 2023 10-Q 21 Aug 2023 2023 Q2
Q1 2023 50,397,762 +7,442,641 +17% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 5,040,236 -38,447,043 -88% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 43,030,885 +39,738,685 +1207% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 43,030,885 +38,356,259 +821% 30 Jun 2022 10-K 14 Apr 2023 2022 FY
Q1 2022 42,955,121 +38,498,530 +864% 31 Mar 2022 10-K 14 Apr 2023 2022 FY
Q4 2021 43,487,279 +17,513,873 +67% 31 Dec 2021 10-K/A 28 Apr 2023 2021 FY
Q3 2021 3,292,200 30 Sep 2021 10-Q 22 Nov 2021 2021 Q3
Q2 2021 4,674,626 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 4,456,591 31 Mar 2021 10-Q 21 May 2021 2021 Q1
Q4 2020 25,973,406 31 Dec 2020 10-K/A 28 Apr 2023 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.